Skip to main content
Log in

Lividfarbener Tumor am Capillitium

  • Wie lautet Ihre Diagnose?
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6

Literatur

  1. Fata F, O’Reilly E, Ilson D et al. (1999) Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 86:2034–2037

    Article  CAS  PubMed  Google Scholar 

  2. Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391–400

    Article  CAS  PubMed  Google Scholar 

  3. Fink-Puches R, Smolle J, Beham A et al. (2000) Kutane Angiosarkome. Hautarzt 51:479–485

    Article  Google Scholar 

  4. Morgan MB, Swann M, Somach S et al. (2004) Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol.50:867–874

    Google Scholar 

  5. Pawlik TM et al. (2003) Scalp Angiosarcoma. Cancer 98:1716–1726

    Article  Google Scholar 

  6. Budd GT (2002) Management of angiosarcoma. Curr Oncol Reports 4:515–519

    Google Scholar 

Download references

Interessenkonflikt:

Keine Angaben

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. W. Neisius.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neisius, U.W., Schuler, G. & Lüftl, M. Lividfarbener Tumor am Capillitium. Hautarzt 56, 778–782 (2005). https://doi.org/10.1007/s00105-004-0858-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-004-0858-5

Navigation